Cabotegravir plus rilpivirine, once a day, after induction with cabotegravir plus nucleoside reverse transcriptase inhibitors in antiretroviral-naive adults with HIV-1 infection (LATTE): a randomised, phase 2b, dose-ranging trial (Q41095343)
Jump to navigation
Jump to search
scientific article published on 17 July 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Cabotegravir plus rilpivirine, once a day, after induction with cabotegravir plus nucleoside reverse transcriptase inhibitors in antiretroviral-naive adults with HIV-1 infection (LATTE): a randomised, phase 2b, dose-ranging trial |
scientific article published on 17 July 2015 |
Statements
1 reference
Cabotegravir plus rilpivirine, once a day, after induction with cabotegravir plus nucleoside reverse transcriptase inhibitors in antiretroviral-naive adults with HIV-1 infection (LATTE): a randomised, phase 2b, dose-ranging trial (English)
1 reference
Joseph J Eron
1 reference
David A Margolis
1 reference
Cynthia C Brinson
1 reference
Graham H R Smith
1 reference
Jerome de Vente
1 reference
Debbie P Hagins
1 reference
Sandy K Griffith
1 reference
Marty H St Clair
1 reference
Marita C Stevens
1 reference
Peter E Williams
1 reference
Susan L Ford
1 reference
Britt S Stancil
1 reference
Melinda M Bomar
1 reference
Krischan J Hudson
1 reference
Kimberly Y Smith
1 reference
William R Spreen
1 reference
LAI116482 Study Team
1 reference
17 July 2015
1 reference
1 reference
1145-1155
1 reference
Identifiers
1 reference